ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,280Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 14

$281K Total Retail Price of All Prescriptions

Rank: 4 out of 14

365 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 365 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 365 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 7,712 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 526 505 1 3
LEVOTHYROXINE SODIUM 489 464 2 1
POTASSIUM CHLORIDE 404 402 3 8
FUROSEMIDE 381 381 4 2
WARFARIN SODIUM 265 265 5 9
LISINOPRIL 255 237 6 6
HYDROCODONE-ACETAMINOPHEN 234 201 S3 7 5
METFORMIN HCL 228 203 8 10
METOPROLOL SUCCINATE 187 184 9 12
OMEPRAZOLE 184 152 10 4
TRIAMTERENE-HCTZ 160 160 11 32
METOPROLOL TARTRATE 160 160 11 13
ALLOPURINOL 156 140 13 20
AMLODIPINE BESYLATE 122 116 14 7
ATENOLOL 122 101 14 11
SPIRONOLACTONE 113 113 16 16
HYDROCHLOROTHIAZIDE 105 100 17 14
NABUMETONE 98 83 18 59
ATORVASTATIN CALCIUM 93 87 19 18
ISOSORBIDE MONONITRATE ER 91 91 20 43
CARVEDILOL 87 83 21 23
GABAPENTIN 84 72 22 17
NAMENDA 75 75 23 41
DIGOXIN 73 72 24 42
TERAZOSIN HCL 72 69 25 54
ESTROPIPATE 70 70 R 26 69
TAMSULOSIN HCL 69 60 27 21
RISPERIDONE 68 66 28 48
FAMOTIDINE 67 62 29 31
POLYETHYLENE GLYCOL 3350 66 61 30 34
DONEPEZIL HCL 65 65 31 22
ENALAPRIL MALEATE 63 63 32 24
GLYBURIDE 60 60 R 33 77
METFORMIN HCL ER 56 56 34 26
LOSARTAN POTASSIUM 56 56 34 19
CITALOPRAM HBR 54 54 36 29
ZOLPIDEM TARTRATE 52 49 37 28
PRAVASTATIN SODIUM 52 45 37 36
SERTRALINE HCL 52 49 37 27
LOSARTAN-HYDROCHLOROTHIAZIDE 51 50 40 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 50 41 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.